EpCAM antibody [ESA 214] (FITC)

GeneTex

EpCAM antibody [ESA 214] (FITC)

9

IHC, ICC (frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, cell smears. For IHC dilute conc. antibodies 1:50-1:100, use streptavidin~biotin system or polymer system, incubate 30 minutes at room temperature. IF, FITC~conjugated antibodies 10-20 microg/ml (1:10-1:20), incubate for 2 hours in the dark at RT or it can also be incubated overnight at 4C. FITC~conjugated antibodies, 0.2-1.0 microg/0.1 ml (1:200-1:1,000)

Flow Cytometry, ImmunoFluorescence, ImmunoCytoChemistry, ImmunoHistoChemistry

Research Use Only

Monoclonal

ESA 214

0.20 mg/ml

FITC

EPCAM

epithelial cell adhesion molecule

Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40, ESA, HNPCC8, KS1/4, KSA, LYNCH8, M4S1, MIC18, MK-1, MOC-31, TACSTD1, TROP1, epithelial cell adhesion molecule, adenocarcinoma-associated antigen, cell surface glycoprotein Trop-1, epithelial glycoprotein 314, human epithelial glycoprotein-2, major gastrointestinal tumor-associated protein GA733-2, membrane component, chromosome 4, surface marker (35kD glycoprotein), trophoblast cell surface antigen 1, tumor-associated calcium signal transducer 1

Mouse

IgG1

Epithelial cell adhesion molecule

This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]

2°C to 8°C

12352203